An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...

Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).

tDCS treatment significantly improves depressive symptoms and boosts clinical response and remission rates, with no serious device-related adverse events reported. Study: Home-based transcranial ...

"It was very surprising that a much lower dose than that recommended by WHO guidelines was still linked with lower risks of depression and depressive symptoms. This is a much more achievable MVPA ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...

For decades, treating major depression has involved a frustrating cycle of trial and error, with patients cycling through ...

Major depressive disorder (MDD) is a debilitating psychiatric condition characterized by a persistently low mood, a lack of ...

Adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with ...

New findings suggest that a protein known as Reelin could play a role in treating both “leaky gut” and severe depression.